Back to Search
Start Over
Eli Lilly announces FDA approval of EBGLYSS
- Source :
- The Fly. September 13, 2024
- Publication Year :
- 2024
-
Abstract
- Eli Lilly and Company announced the U.S. FDA approved EBGLYSS, a targeted IL-13 inhibitor, for the treatment of adults and children 12 years of age and older who weigh at [...]
Details
- Language :
- English
- Database :
- Gale General OneFile
- Journal :
- The Fly
- Publication Type :
- Periodical
- Accession number :
- edsgcl.808607306